COX-2–Selective NSAIDs
David R. Lichtenstein, M. Michael Wolfe · JAMA · 2000
Cited by 54 works. doi:10.1001/jama.284.10.1297
Authors
References
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
- Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs
- Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
- Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
- Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
- Prophylactic aspirin and risk of peptic ulcer bleeding
- Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
- Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDs